Detailansicht

Wissensnetz

Person

Peter Malfertheiner (1950-)

Arzt

Name	Peter Malfertheiner
Zeit	1950- (Lebensdaten)
Ort	Magdeburg (Wirkungsort) Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Professor Dr. med. habil. Dr. h. c.
Beruf	Arzt (charakteristischer Beruf)
Variante	... Malfertheiner P. Melfertheiner
Weitere Angaben	Direktor der Klinik für Gastroenterologie, Hepatologie und Infektiologie der Otto-von-Guericke-Universität Magdeburg
Datensatztyp	Person
GND-Nummer	110963946
Datensatz-ID	110963946
Beteiligt an alle anzeigen Update S2k-Guideline Helicobacter pylori and gastroduodenal ulcer disease of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) : August 2023 – AWMF-Registernummer: 021–001 miRNome Profiling Analysis Reveals Novel Hepatocellular Carcinoma Diagnostic, Prognostic and Treatment-Related Candidate Biomarkers: Post hoc Analysis of SORAMIC Trial Helicobacter pylori Infection: A 40-Year Journey through Shifting the Paradigm to Transforming the Management Poliprotect für das Management von epigastrischem Schmerz und Sodbrennen : ein nachhaltiges Nutzen-Risiko-Verhältnis für Patienten und Umwelt Microbial composition of tumorous and adjacent gastric tissue is associated with prognosis of gastric cancer Development and External Validation of the Munich Sorafenib Evaluation Score for Hepatocellular Carcinoma Pankreatin : Enzymsubstitution bei exokriner Pankreasinsuffizienz DNA methylation in human gastric epithelial cells defines regional identity without restricting lineage plasticity Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progression Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib The Fear of Gastric Cancer in Patients with Dyspepsia: Challenge in Specialist Care Gastroenterology Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib Extracellular Vesicles May Predict Response to Radioembolization and Sorafenib Treatment in Advanced Hepatocellular Carcinoma : An Exploratory Analysis from the SORAMIC Trial Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial Correlation of liver enhancement in gadoxetic acid–enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial Prognostic value of baseline interleukin 6 levels in liver decompensation and survival in HCC patients undergoing radioembolization Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial Prävention gastrointestinaler Tumore COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist Gut microbiota profiles and the role of anti-CdtB and anti-vinculin antibodies in patients with functional gastrointestinal disorders (FGID) Correlation of skin rash and overall survival in patients with pancreatic cancer treated with gemcitabine and erlotinib – results from a non-interventional multi-center study Impact of Extrahepatic Metastases on Overall Survival in Patients with Advanced Liver Dominant Hepatocellular Carcinoma: A Subanalysis of the SORAMIC Trial COVID-19: Don’t Neglect the Gastrointestinal Tract! Peptic Ulcer: Chapter Closed? Blue Light Imaging and Linked Color Imaging for the Characterization of Mucosal Changes in Chronic Gastritis: A Clinicians View and Brief Technical Report Fusobacterium nucleatum is associated with worse prognosis in Lauren´s diffuse type gastric cancer patients Impact of Extrahepatic Metastases on Overall Survival in Patients with Advanced Liver Dominant Hepatocellular Carcinoma: A Subanalysis of the SORAMIC Trial Review : prevention and management of gastric cancer Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus What is the Relevance of Gastric Microbiota Beyond H. pylori? Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial Within-host evolution of Helicobacter pylori shaped by niche-specific adaptation, intragastric migrations and selective sweeps The Rationale and Efficacy of Primary and Secondary Prevention in Adenocarcinomas of the Upper Gastrointestinal Tract Long-Term Effect of Rifaximin with and without Lactulose on the Active Bacterial Assemblages in the Proximal Small Bowel and Faeces in Patients with Minimal Hepatic Encephalopathy Maintenance therapy with FOLFIRI after FOLFIRINOX for advanced pancreatic ductal adenocarcinoma : a retrospective single-center analysis The role of the gastric bacterial microbiome in gastric cancer: Helicobacter pylori and beyond Radioablation by Image-Guided (HDR) Brachytherapy and Transarterial Chemoembolization in Hepatocellular Carcinoma: A Randomized Phase II Trial Helicobacter pylori Infection: New Facts in Clinical Management STW 5 (Iberogast) Therapy in Gastrointestinal Functional Disorders Functional Gastrointestinal Disorders: Complex Treatments for Complex Pathophysiological Mechanisms Combined Systemic Chemotherapy and CT-Guided High-Dose-Rate Brachytherapy for Isolated Local Manifestation of Pancreatic Cancer after Surgical Resection Mucosal Two-Step Pathogenesis in Gastroesophageal Reflux Disease: Repeated Weakly Acidic Stimulation and Activation of Protease-Activated Receptor-2 on Mucosal Interleukin-8 Secretion The Iceman's Last Meal Consisted of Fat, Wild Meat, and Cereals The prevalence of gastric heterotopia of the proximal esophagus is underestimated, but preneoplasia is rare - correlation with Barrett’s esophagus Magenkarzinom: Risikopatienten identifizieren und Schlimmeres verhindern Recurrent diffuse gastric bleeding as a leading symptom of gastrointestinal AL amyloidosis Prevalence of Helicobacter pylori infection among blood donors in Saxony-Anhalt, Germany – a region at intermediate risk for gastric cancer Management of Helicobacter pylori Infection: What Should the Surgeon Know Road Map fluoroscopy successfully guides endoscopic interventions in the esophagus Das gastrointestinale Mikrobiom : Wechselspiel von Kommensalität und Pathogenität Influence of laboratory-related and endoscopy-related factors on the assessment of serum pepsinogens and gastrin-17 RiMINI – the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial Gastric and gut microbiota in health and disease Anatomy-shaped design of a fully-covered, biliary, self-expandable metal stent for treatment of benign distal biliary strictures A novel approach to esophageal stent removal in the setting of proximal stenosis and failure of the primary retrieval mechanism Cone-beam computed tomography – adding a new dimension to ERCP Was ist neu bei der Behandlung der Helicobacter-pylori-Infektion? Challenges in inflammatory, preneoplastic and neoplastic diseases of the digestive system : 19 tables Performance and value of IFN-lambda3 and IFN-lambda4 genotyping in patients with chronic hepatitis C (CHC) genotype 2/3 in a real world setting

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Peter Malfertheiner (1950-)

Update S2k-Guideline Helicobacter pylori and gastroduodenal ulcer disease of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) : August 2023 – AWMF-Registernummer: 021–001

miRNome Profiling Analysis Reveals Novel Hepatocellular Carcinoma Diagnostic, Prognostic and Treatment-Related Candidate Biomarkers: Post hoc Analysis of SORAMIC Trial

Helicobacter pylori Infection: A 40-Year Journey through Shifting the Paradigm to Transforming the Management

Poliprotect für das Management von epigastrischem Schmerz und Sodbrennen : ein nachhaltiges Nutzen-Risiko-Verhältnis für Patienten und Umwelt

Microbial composition of tumorous and adjacent gastric tissue is associated with prognosis of gastric cancer

Development and External Validation of the Munich Sorafenib Evaluation Score for Hepatocellular Carcinoma

Pankreatin : Enzymsubstitution bei exokriner Pankreasinsuffizienz

DNA methylation in human gastric epithelial cells defines regional identity without restricting lineage plasticity

Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib

Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progression

Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib

The Fear of Gastric Cancer in Patients with Dyspepsia: Challenge in Specialist Care Gastroenterology

Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib

Extracellular Vesicles May Predict Response to Radioembolization and Sorafenib Treatment in Advanced Hepatocellular Carcinoma : An Exploratory Analysis from the SORAMIC Trial

Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial

Correlation of liver enhancement in gadoxetic acid–enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial

Prognostic value of baseline interleukin 6 levels in liver decompensation and survival in HCC patients undergoing radioembolization

Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial

Prävention gastrointestinaler Tumore

COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist

Gut microbiota profiles and the role of anti-CdtB and anti-vinculin antibodies in patients with functional gastrointestinal disorders (FGID)

Correlation of skin rash and overall survival in patients with pancreatic cancer treated with gemcitabine and erlotinib – results from a non-interventional multi-center study

Impact of Extrahepatic Metastases on Overall Survival in Patients with Advanced Liver Dominant Hepatocellular Carcinoma: A Subanalysis of the SORAMIC Trial

COVID-19: Don’t Neglect the Gastrointestinal Tract!

Peptic Ulcer: Chapter Closed?

Blue Light Imaging and Linked Color Imaging for the Characterization of Mucosal Changes in Chronic Gastritis: A Clinicians View and Brief Technical Report

Fusobacterium nucleatum is associated with worse prognosis in Lauren´s diffuse type gastric cancer patients

Impact of Extrahepatic Metastases on Overall Survival in Patients with Advanced Liver Dominant Hepatocellular Carcinoma: A Subanalysis of the SORAMIC Trial

Review : prevention and management of gastric cancer

Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus

What is the Relevance of Gastric Microbiota Beyond H. pylori?

Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial

Within-host evolution of Helicobacter pylori shaped by niche-specific adaptation, intragastric migrations and selective sweeps

The Rationale and Efficacy of Primary and Secondary Prevention in Adenocarcinomas of the Upper Gastrointestinal Tract

Long-Term Effect of Rifaximin with and without Lactulose on the Active Bacterial Assemblages in the Proximal Small Bowel and Faeces in Patients with Minimal Hepatic Encephalopathy

Maintenance therapy with FOLFIRI after FOLFIRINOX for advanced pancreatic ductal adenocarcinoma : a retrospective single-center analysis

The role of the gastric bacterial microbiome in gastric cancer: Helicobacter pylori and beyond

Radioablation by Image-Guided (HDR) Brachytherapy and Transarterial Chemoembolization in Hepatocellular Carcinoma: A Randomized Phase II Trial

Helicobacter pylori Infection: New Facts in Clinical Management

STW 5 (Iberogast) Therapy in Gastrointestinal Functional Disorders

Functional Gastrointestinal Disorders: Complex Treatments for Complex Pathophysiological Mechanisms

Combined Systemic Chemotherapy and CT-Guided High-Dose-Rate Brachytherapy for Isolated Local Manifestation of Pancreatic Cancer after Surgical Resection

Mucosal Two-Step Pathogenesis in Gastroesophageal Reflux Disease: Repeated Weakly Acidic Stimulation and Activation of Protease-Activated Receptor-2 on Mucosal Interleukin-8 Secretion

The Iceman's Last Meal Consisted of Fat, Wild Meat, and Cereals

The prevalence of gastric heterotopia of the proximal esophagus is underestimated, but preneoplasia is rare - correlation with Barrett’s esophagus

Magenkarzinom: Risikopatienten identifizieren und Schlimmeres verhindern

Recurrent diffuse gastric bleeding as a leading symptom of gastrointestinal AL amyloidosis

Prevalence of Helicobacter pylori infection among blood donors in Saxony-Anhalt, Germany – a region at intermediate risk for gastric cancer

Management of Helicobacter pylori Infection: What Should the Surgeon Know

Road Map fluoroscopy successfully guides endoscopic interventions in the esophagus

Das gastrointestinale Mikrobiom : Wechselspiel von Kommensalität und Pathogenität

Influence of laboratory-related and endoscopy-related factors on the assessment of serum pepsinogens and gastrin-17

RiMINI – the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial

Gastric and gut microbiota in health and disease

Anatomy-shaped design of a fully-covered, biliary, self-expandable metal stent for treatment of benign distal biliary strictures

A novel approach to esophageal stent removal in the setting of proximal stenosis and failure of the primary retrieval mechanism

Cone-beam computed tomography – adding a new dimension to ERCP

Was ist neu bei der Behandlung der Helicobacter-pylori-Infektion?

Challenges in inflammatory, preneoplastic and neoplastic diseases of the digestive system : 19 tables

Performance and value of IFN-lambda3 and IFN-lambda4 genotyping in patients with chronic hepatitis C (CHC) genotype 2/3 in a real world setting